TOXICITY
Clinical trials for TOXICITY explained in plain language.
Never miss a new study
Get alerted when new TOXICITY trials appear
Sign up with your email to follow new studies for TOXICITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can shrinking radiation margins reduce lung damage without losing cancer control?
Disease control Recruiting nowThis study tests whether removing extra safety margins in adaptive stereotactic radiotherapy can lower the risk of breathing problems for people with early-stage non-small cell lung cancer or limited lung metastases. About 130 participants will be randomly assigned to standard or…
Matched conditions: TOXICITY
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 07, 2026 18:40 UTC
-
Fatty acid supplement may tame Radiation's gut punch
Symptom relief Recruiting nowThis study tests whether taking short-chain fatty acid (SCFA) supplements can reduce stomach and bowel side effects caused by radiation therapy for cancers in the belly or pelvis. About 122 adults receiving such radiation will be randomly assigned to get either the supplement or …
Matched conditions: TOXICITY
Phase: PHASE1, PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Symptom relief
Last updated May 16, 2026 23:36 UTC
-
New study aims to make cancer care safer for seniors
Knowledge-focused Recruiting nowThis study looks at whether a quick, practical geriatric assessment can help doctors better tailor cancer treatments for adults aged 70 and older with advanced cancer. About 150 participants will be tracked to see how often the assessment is completed and whether it leads to safe…
Matched conditions: TOXICITY
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC
-
Can your body shape predict chemo toxicity? new study investigates
Knowledge-focused Recruiting nowThis study looks at how a person's muscle mass (fat-free mass) relates to side effects from standard chemotherapy (carboplatin/paclitaxel) in advanced non-small cell lung cancer. Researchers will track 132 participants to see if adjusting the chemo dose based on body composition …
Matched conditions: TOXICITY
Sponsor: Instituto Nacional de Cancerologia de Mexico • Aim: Knowledge-focused
Last updated May 11, 2026 20:39 UTC